| Bennett John Pastika, DO | |
|
855 N Westhaven Dr, Oshkosh, WI 54904-7668 | |
| (920) 303-8700 | |
| Not Available |
| Full Name | Bennett John Pastika |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 37 Years |
| Location | 855 N Westhaven Dr, Oshkosh, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467448977 | NPI | - | NPPES |
| 30062100 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 036077460 (Illinois) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 35507 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Ctr Oshkosh | Oshkosh, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
C2 Health, a division of C2 Technologies, Inc., announced today the launch of its Health Exchange Learning Portal (HELP) at C2-Health.com, a complete suite of classroom, eLearning courses, and resources for nationwide education of Navigators/Consumer Assistors, Consumers, Brokers, Call Center Representatives (CSRs), Health Workers and Volunteers tasked with helping consumers enroll for healthcare coverage under the Affordable Care Act of 2010 (ACA).
Invasive fungal infections (IFI) are a major threat to individuals with cancer, transplants, HIV, and other conditions that weaken their immune system. New research has shown that radioimmunotherapy (RIT) could be a promising avenue for development of new types of treatment of fungal diseases, according to a paper published by scientists of the Joint Research Centre (JRC) in collaboration with other researchers.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the entire equity interest in Zhejiang Wansheng Pharmaceutical Co., Ltd a limited liability company incorporated in the PRC for an aggregate consideration of RMB 528 million.
PRA International, a leading Clinical Research Organization, announces it has entered into a partnership agreement with Oncopartners, a leading Latin American oncology development company, and its exclusive partner IBPC, a non-profit oncology research network comprised of Brazil's largest public oncology hospitals which collectively treat an estimated 140,000 new incidences of cancer annually.
DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.
› Verified 3 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
C2 Health, a division of C2 Technologies, Inc., announced today the launch of its Health Exchange Learning Portal (HELP) at C2-Health.com, a complete suite of classroom, eLearning courses, and resources for nationwide education of Navigators/Consumer Assistors, Consumers, Brokers, Call Center Representatives (CSRs), Health Workers and Volunteers tasked with helping consumers enroll for healthcare coverage under the Affordable Care Act of 2010 (ACA).
Invasive fungal infections (IFI) are a major threat to individuals with cancer, transplants, HIV, and other conditions that weaken their immune system. New research has shown that radioimmunotherapy (RIT) could be a promising avenue for development of new types of treatment of fungal diseases, according to a paper published by scientists of the Joint Research Centre (JRC) in collaboration with other researchers.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the entire equity interest in Zhejiang Wansheng Pharmaceutical Co., Ltd a limited liability company incorporated in the PRC for an aggregate consideration of RMB 528 million.
PRA International, a leading Clinical Research Organization, announces it has entered into a partnership agreement with Oncopartners, a leading Latin American oncology development company, and its exclusive partner IBPC, a non-profit oncology research network comprised of Brazil's largest public oncology hospitals which collectively treat an estimated 140,000 new incidences of cancer annually.
DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bennett John Pastika, DO 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (414) 389-2131 | Bennett John Pastika, DO 855 N Westhaven Dr, Oshkosh, WI 54904-7668 Ph: (920) 303-8700 |
News Archive
C2 Health, a division of C2 Technologies, Inc., announced today the launch of its Health Exchange Learning Portal (HELP) at C2-Health.com, a complete suite of classroom, eLearning courses, and resources for nationwide education of Navigators/Consumer Assistors, Consumers, Brokers, Call Center Representatives (CSRs), Health Workers and Volunteers tasked with helping consumers enroll for healthcare coverage under the Affordable Care Act of 2010 (ACA).
Invasive fungal infections (IFI) are a major threat to individuals with cancer, transplants, HIV, and other conditions that weaken their immune system. New research has shown that radioimmunotherapy (RIT) could be a promising avenue for development of new types of treatment of fungal diseases, according to a paper published by scientists of the Joint Research Centre (JRC) in collaboration with other researchers.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the entire equity interest in Zhejiang Wansheng Pharmaceutical Co., Ltd a limited liability company incorporated in the PRC for an aggregate consideration of RMB 528 million.
PRA International, a leading Clinical Research Organization, announces it has entered into a partnership agreement with Oncopartners, a leading Latin American oncology development company, and its exclusive partner IBPC, a non-profit oncology research network comprised of Brazil's largest public oncology hospitals which collectively treat an estimated 140,000 new incidences of cancer annually.
DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.
› Verified 3 days ago
Zahid N Dar, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 | |
Dr. Brian A.w. Temple, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 Fax: 920-303-8992 | |
Anita I Gheller-rigoni, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-456-5900 Fax: 920-456-5901 | |
Maye R Berroya, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-456-7408 | |
Dr. Benjamin Joseph Heinzen, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1855 S Koeller St, Oshkosh, WI 54902 Phone: 920-223-7100 | |
Mamoun B Al-nouri, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2700 W 9th Ave, Ste 106, Oshkosh, WI 54904 Phone: 920-236-1755 | |
Robert D. Geck, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 |